Alinka Socorro García-Camacho

ORCID: 0000-0002-6657-394X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Hepatitis B Virus Studies
  • CNS Lymphoma Diagnosis and Treatment
  • HIV, Drug Use, Sexual Risk
  • Chronic Lymphocytic Leukemia Research
  • Blood groups and transfusion
  • Travel-related health issues
  • Hepatitis C virus research
  • Malaria Research and Control
  • Eosinophilic Disorders and Syndromes
  • Hematological disorders and diagnostics
  • Hemoglobinopathies and Related Disorders
  • Parasites and Host Interactions
  • Vascular Tumors and Angiosarcomas
  • Parasitic Infections and Diagnostics
  • Coccidia and coccidiosis research
  • Autoimmune Bullous Skin Diseases
  • Neutropenia and Cancer Infections
  • Platelet Disorders and Treatments
  • Poverty, Education, and Child Welfare
  • Venous Thromboembolism Diagnosis and Management
  • Blood disorders and treatments

Centro Medico Nacional Siglo XXI
2021-2023

Hospital de Especialidades
2023

Mexican Social Security Institute
2021-2022

Instituto Mexicano de Oftalmología IAP
2022

Universidad Autónoma del Estado de Hidalgo
2018

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2018

Hospital Universitario Ramón y Cajal
1992-1999

The number of Spanish travelers visiting malaria endemic areas, and the immigrants from malarial countries arriving in Spain are continuously increasing. However, little information about imported cases is available.A prospective clinicoepidemiological study diagnosed at a referral teaching hospital Madrid, Spain.Of 160 patients, sixty (37.5%) were 100 (62.5%) nationals. Malaria was acquired Africa by 98.3% 83.0% travelers. Falciparum accounted for 71.8% cases, P. vivax 11.9%, ovale 10.6%...

10.1111/j.1708-8305.1999.tb00837.x article EN Journal of Travel Medicine 1999-06-01

The approach to HCV infection begins with the directed search for risk factors linked its acquisition. Therefore, our primary aim was identify prevalence of associated infections in insured individuals seen at Hidalgo delegation IMSS.An observational, descriptive, cross-sectional study conducted through validated surveys that identified major and minor factors. In cases factors, Advanced Quality™ RAPID-ANTI-HCV TEST Accutrack® tests were applied detect anti-HCV. Patients positive referred...

10.1016/j.rgmx.2018.02.012 article EN cc-by-nc-nd Revista de Gastroenterología de México 2018-06-09
Luara L. Arana-Luna Martha Alvarado‐Ibarra Luis G. Silva-Michel Adrián Morales-Maravilla María del C. González-Rubio and 76 more Lénica A. Chávez-Aguilar Ma. Fernanda Tena-Iturralde Liliana Mojica-Balceras Nidia Zapata-Canto Patricia Galindo-Delgado Ma. Raquel Miranda-Madrazo Alba E. Morales-Hernández Karina Silva-Vera Flavio Adrián Grimaldo-Gómez Álvaro Hernández-Caballero Ramón A. Bates-Martín José L. Álvarez-Vera Fredy Tepepa-Flores Óscar Teomitzi-Sánchez Denisse Jocelyn Fermín-Caminero José A. de la Peña-Celaya Óscar Salazar-Ramírez Luz Victoria Flores‐Villegas Lidia V. Guerra-Alarcón Faustino Leyto-Cruz Sergio I. Inclán-Alarcón Andrea I. Milán-Salvatierra Yanet Ventura-Enríquez Uendy Pérez-Lozano Pamela E. Báez-Islas Ana Laura Tapia-Enríquez Orlando G. Palma-Moreno Jocelyn Aguilar-Luévano Arturo Espinosa-Partida Fernando Pérez‐Jacobo Flavio Rojas-Castillejos Josué I. Ruiz-Contreras Sergio José Loera-Fragoso Jesús E. Medina-Coral Brenda L. Acosta‐Maldonado Emely J. Soriano-Mercedes Erick E. Saucedo-Montes Luis Manuel Valero-Saldaña Susana G. González-Prieto Lorena Nava-Villegas Ana K. Hernández-Colín Areli E. Hernández-Alcántara Pedro A. Zárate-Rodríguez Gregorio Ignacio-Ibarra Luis Antonio Meillón‐García Karla Espinosa‐Bautista Cindy Ledesma-de la Cruz Diego M. Barbosa-Loría Carolina García-Castillo Carolina Balderas-Delgado Álvaro Cabrera-García Juan Manuel Pérez-Zúñiga Eleazar Hernández-Ruiz Atenas Villela-Peña Sue C. Gómez Cortés Hilda Romero-Rodelo Katheryn B. Garzón-Velásquez Cristina Serrano-Hernández Annel Martínez-Ríos Ma. Luisa Pedraza-Colín Jorge Martínez-Coronel Iris M. Narváez-Davalos Alinka Socorro García-Camacho Laura Elizabeth Merino‐Pasaye Carolina Aguilar-Andrade Juan A. Aguirre-Domínguez Pedro G. Guzmán-Mera Elizabeth Delgado-de la Rosa Perla E. Flores López Lilia L. González-Aguirre Edgar M. Ramírez-Alfaro Heidi Vera-Calderón Ma. Lizeth Meza-Dávalos Juan Murillo-Cruz Yayra M. Pichardo-Cepín Eva Fabiola Ramirez-Romero

Acute myeloid leukemia (AML) comprises a heterogeneous group of hematopoietic cell neoplasms lineage that arise from the clonal expansion their precursors in bone marrow, interfering with differentiation, leading to syndrome marrow failure. AML is consequence genetic and epigenetic changes (point mutations, gene rearrangements, deletions, amplifications, arrangements influence expression) precursor cells, which create clone abnormal cells are capable proliferating but cannot differentiate...

10.24875/gmm.m21000598 article ES cc-by-nc-nd Gaceta Médica de México 2022-03-24

The approach to HCV infection begins with the directed search for risk factors linked its acquisition. Therefore, our primary aim was identify prevalence of associated infections in insured individuals seen at Hidalgo delegation IMSS. An observational, descriptive, cross-sectional study conducted through validated surveys that identified major and minor factors. In cases factors, Advanced Quality™ RAPID-ANTI-HCV TEST Accutrack® tests were applied detect anti-HCV. Patients positive referred...

10.1016/j.rgmxen.2018.08.004 article ES cc-by-nc-nd Revista de Gastroenterología de México (English Edition) 2018-09-12

Hodgkin's lymphoma (HL) is due to the clonal transformation of cells originating from B lymphocytes, generating pathognomonic binucleate Reed-Sternberg cells.HL a cell disease with bimodal distribution, higher incidence in adolescence and third decade life, showing second peak people over 55 years age.Classic Hodgkin routinely undergo gene expression reprogramming, as they lose most typical B-cell genes acquire multiple that are other types immune system.The treatment algorithm will

10.24875/gmm.m21000500 article EN cc-by-nc-nd Gaceta Médica de México 2021-06-25

El linfoma de Hodgkin (LH) se debe a la transformación clonal células originadas en los linfocitos B, lo que genera las binucleadas patognomónicas Reed-Sternberg. LH es una enfermedad B con distribución bimodal, mayor incidencia adolescencia y tercera década vida un segundo pico personas mayores 55 años. Las del clásico habitualmente sufren reprogramación expresión génica, ya pierden mayoría genes típicos han adquirido múltiples son otros tipos sistema inmunitario. algoritmo tratamiento...

10.24875/gmm.m21000534 article ES cc-by-nc-nd Gaceta Médica de México 2021-07-15
Gilberto Barranco-Lampón Raúl Martínez-Castro Luara L. Arana-Luna José L. Álvarez-Vera Flavio Rojas-Castillejos and 75 more Rosalinda Peñaloza-Ramírez Adrián A. Carballo‐Zarate Irma Olarte-Carrillo Jaime Israel-García Minamy Javier López‐Salazar Juan José Cervantes Navarrete Arturo Espinosa-Partida Yanet Ventura-Enríquez Josué I. Ruiz-Contreras Oyuky G. Aguirre-Reyes Irene Anaya-Cuéllar Jocelyn Aguilar-Luévano Hugo Francisco Díaz-Ramírez Wilfrido Herrera-Olivares José Antonio Aguilar-Hidalgo Luisa Ma Alcívar-Cedeño Álvaro Hernández-Caballero Lourdes Elena Galaz-Cordero José A. de la Peña-Celaya Pamela E. Báez-Islas Ramón Alberto Bates-Martín Ana Ma de la Luz Cano-León Ma. Eugenia Espitia-Ríos Diego Barbosa Javier Morales-Adrián Martín Jacobo Pacheco Nancy Delgado-López Yvette Neme-Yunes Alba Edna Moralws-Hernández Aldo Mújica-Martínez Alejandra B. Pérez-Lizardi Karen D. Pérez-Gómez Gabriel Barragán-Ibáñez Adolfo Martínez Tovar Karen Flores-Ordúñez Paulina Ramírez-Hoyos Ma de Los Ángeles Rosales-López Brenda L. Acosta‐Maldonado Marco A. Jiménez-Ochoa Katheryn B. Garzón-Velásquez Eleazar Hernández-Ruiz Bosco Martín McNally-Guillén Erick E. Saucedo-Montes Carolina Aguilar-Andrade Cindy Lissette Vivas-Arteaga Lidia V. Guerra-Alarcón Andrea I. Milán-Salvatierra Dafne Itzel Campa-Monroy Xóchitl Cota-Rangel Patricia Estrada-Domínguez Alinka Socorro García-Camacho Carolina García-Castillo Luisa I. Banda-García Vania Rodríguez-Sánchez Luis Antonio Meillón‐García Elizabeth Urbina-Escalante Mario A. Martínez-Ramírez Sergio José Loera-Fragoso Jorge Martínez-Coronel Nidia Zapata-Canto Sue Cynthia Gómez-Cortés Jesús Emanuel Medina-Coral Liliana Mójica-Balderas Juan Manuel Pérez-Zúñiga Fernando Jacobo Pérez José L. López-Arroyo Juan F. Zazueta-Pozos Eduardo Romero-Martínez Hilda Romero-Rodelo Ana Laura Tapia-Enríquez Emely J. Soriano-Mercedes Óscar Salazar-Ramírez Shendel P. Vilchis-González Fredy Tepepa-Flores Martha Alvarado‐Ibarra

In addition to symptoms secondary splenomegaly, microvascular abnormalities, and thrombohemorrhagic complications, patients with MPN may experience a significant symptom burden attributed an increase in circulating inflammatory cytokines. These can be severe limit quality of life. Therefore, the prevention one objectives treatment is control symptoms.Además de la sintomatología secundaria esplenomegalia, las alteraciones microvasculares y complicaciones trombohemorrágicas, los pacientes con...

10.24875/gmm.m22000809 article ES cc-by-nc-nd Gaceta Médica de México 2023-09-11
Gilberto Barranco-Lampón Raúl Martínez-Castro Luara L. Arana-Luna José L. Álvarez-Vera Flavio Rojas-Castillejos and 75 more Rosalinda Peñaloza-Ramírez Adrián A. Carballo‐Zarate Irma Olarte-Carrillo Jaime Israel-García Minamy Javier López‐Salazar Juan José Cervantes Navarrete Arturo Espinosa-Partida Yanet Ventura-Enríquez Josué I. Ruiz-Contreras Oyuky G. Aguirre-Reyes Irene Anaya-Cuéllar Jocelyn Aguilar-Luévano Hugo Francisco Díaz-Ramírez Wilfrido Herrera-Olivares José Antonio Aguilar-Hidalgo Luisa Ma Alcívar-Cedeño Álvaro Hernández-Caballero Lourdes Elena Galaz-Cordero José A. de la Peña-Celaya Pamela E. Báez-Islas Ramón Alberto Bates-Martín Ana Ma de la Luz Cano-León Ma. Eugenia Espitia-Ríos Diego Barbosa Javier Morales-Adrián Martín Jacobo Pacheco Nancy Delgado-López Yvette Neme-Yunes Alba Edna Moralws-Hernández Aldo Mújica-Martínez Alejandra B. Pérez-Lizardi Karen D. Pérez-Gómez Gabriel Barragán-Ibáñez Adolfo Martínez Tovar Karen Flores-Ordúñez Paulina Ramírez-Hoyos Ma. de los Ángeles Rosales-López Brenda L. Acosta‐Maldonado Marco A. Jiménez-Ochoa Katheryn B. Garzón-Velásquez Eleazar Hernández-Ruiz Bosco Martín McNally-Guillén Erick E. Saucedo-Montes Carolina Aguilar-Andrade Cindy Lissette Vivas-Arteaga Lidia V. Guerra-Alarcón Andrea I. Milán-Salvatierra Dafne Itzel Campa-Monroy Xóchitl Cota-Rangel Patricia Estrada-Domínguez Alinka Socorro García-Camacho Carolina García-Castillo Luisa I. Banda-García Vania Rodríguez-Sánchez Luis Antonio Meillón‐García Elizabeth Urbina-Escalante Mario A. Martínez-Ramírez Sergio José Loera-Fragoso Jorge Martínez-Coronel Nidia Zapata-Canto Sue Cynthia Gómez-Cortés Jesús Emanuel Medina-Coral Liliana Mójica-Balderas Juan Manuel Pérez-Zúñiga Fernando Jacobo Pérez José L. López-Arroyo Juan F. Zazueta-Pozos Eduardo Romero-Martínez Hilda Romero-Rodelo Ana Laura Tapia-Enríquez Emely J. Soriano-Mercedes Óscar Salazar-Ramírez Shendel P. Vilchis-González Fredy Tepepa-Flores Martha Alvarado‐Ibarra

Myeloproliferative neoplasms (MPN) are associated with a significant risk of thrombosis and the hypercoagulable environment pregnancy increases this risk. The most frequent gestational complications consist spontaneous abortion, thrombosis, bleeding, hypertensive disease pregnancy. Treatment depends on thrombotic risk, trimester, myeloproliferative neoplasm.

10.24875/gmm.m22000807 article EN cc-by-nc-nd Gaceta Médica de México 2023-09-11
Gilberto Barranco-Lampón Raúl Martínez-Castro Luara L. Arana-Luna José L. Álvarez-Vera Flavio Rojas-Castillejos and 75 more Rosalinda Peñaloza-Ramírez Adrián A. Carballo‐Zarate Irma Olarte-Carrillo Jaime Israel-García Minamy Javier López‐Salazar Juan José Cervantes Navarrete Arturo Espinosa-Partida Yanet Ventura-Enríquez Josué I. Ruiz-Contreras Oyuky G. Aguirre-Reyes Irene Anaya-Cuéllar Jocelyn Aguilar-Luévano Hugo Francisco Díaz-Ramírez Wilfrido Herrera-Olivares José Antonio Aguilar-Hidalgo Luisa Ma Alcívar-Cedeño Álvaro Hernández-Caballero Lourdes Elena Galaz-Cordero José A. de la Peña-Celaya Pamela E. Báez-Islas Ramón Alberto Bates-Martín Ana Ma de la Luz Cano-León Ma. Eugenia Espitia-Ríos Diego Barbosa Javier Morales-Adrián Martín Jacobo Pacheco Nancy Delgado-López Yvette Neme-Yunes Alba Edna Moralws-Hernández Aldo Mújica-Martínez Alejandra B. Pérez-Lizardi Karen D. Pérez-Gómez Gabriel Barragán-Ibáñez Adolfo Martínez Tovar Karen Flores-Ordúñez Paulina Ramírez-Hoyos Ma de Los Ángeles Rosales-López Brenda L. Acosta‐Maldonado Marco A. Jiménez-Ochoa Katheryn B. Garzón-Velásquez Eleazar Hernández-Ruiz Bosco Martín McNally-Guillén Erick E. Saucedo-Montes Carolina Aguilar-Andrade Cindy Lissette Vivas-Arteaga Lidia V. Guerra-Alarcón Andrea I. Milán-Salvatierra Dafne Itzel Campa-Monroy Xóchitl Cota-Rangel Patricia Estrada-Domínguez Alinka Socorro García-Camacho Carolina García-Castillo Luisa I. Banda-García Vania Rodríguez-Sánchez Luis Antonio Meillón‐García Elizabeth Urbina-Escalante Mario A. Martínez-Ramírez Sergio José Loera-Fragoso Jorge Martínez-Coronel Nidia Zapata-Canto Sue Cynthia Gómez-Cortés Jesús Emanuel Medina-Coral Liliana Mójica-Balderas Juan Manuel Pérez-Zúñiga Fernando Jacobo Pérez José L. López-Arroyo Juan F. Zazueta-Pozos Eduardo Romero-Martínez Hilda Romero-Rodelo Ana Laura Tapia-Enríquez Emely J. Soriano-Mercedes Óscar Salazar-Ramírez Shendel P. Vilchis-González Fredy Tepepa-Flores Martha Alvarado‐Ibarra

Polycythemia vera (PV) is mainly characterized by erythrocytosis, thrombotic and hemorrhagic predisposition, a variety of symptoms, cumulative risks fibrotic progression and/or leukemic evolution over time. The diagnosis made based on the 2016 WHO criteria. treatment PV focuses rapidly reducing erythrocyte mass, either means phlebotomies or with cytoreductive treatment, reduction risk correcting cardiovascular factors use platelet antiaggregants.

10.24875/gmm.m22000802 article EN cc-by-nc-nd Gaceta Médica de México 2023-09-11
Coming Soon ...